Research

A 16 Week Evaluation of the Novartis Health Management Tool (HMT) in Age Related Macular Degeneration (AMD)

This is a prospective pilot study to evaluate the usability and applicability of a self monitoring test of visual function with the handheld Health.

Continue Reading

What Insights Will You Gain?

This is a completed Novartis-sponsored trial (NCT01542866) that tested a handheld "Health Management Tool" (HMT) letting AMD patients self-test their vision at home over 16 weeks. Run with tech partners Carematix and VAS, the 160-patient study aimed to see if home testing could reliably catch disease worsening between clinic visits, comparing HMT results against standard clinical measures (BCVA, OCT). How remote/self-monitoring tools are validated against clinical gold standards, why patient compliance and satisfaction matter for such tools to work in practice, and how pharma companies partner with health-tech firms to build monitoring into treatment programs.